Hi Stimpsonsocal,really appreciate the response and insights you...

Hi Stimpsonsocal,

really apprecia

te the response and insights you can provide and great to have a local American insight

Giod to hear Elixinol are competitive and well organised on the e-commerce side.

it seems we are still early in in the journey of CBD and there is a lot more to come. Some of the main catalysts we are waiting for with the stock are 1) granting of medical marijuana licence 2) passing of the US farming bill which will legalise hemp and CBD on a federal level 3) potential acquisition with the $40m raised..

it will also be interesting to see how their international expansion goes as they appear to have good traction in Japan, UK and South Africa. I am sure we are going to see more plans for Europe as well with a big focus on the brand and direct sales through their online channel.

interesting observations about the in store presence and store finder recommendation. This should be very helpful and as an active shareholder I would e-mail the suggestion to the CEO

[email protected]

Like I said previously EXL is the only profitable Hemp/CBD stock on the ASX and I am expecting sales Revenue/Turnover to come in at $9.5m for the current quarter and for the growth trend to accelerate as legalisation helps with distribution.

if you have any other insights on the CBD market and Elixinol as a company would be really appreciated as we could do with as many contributors as possible on this forum.